NeuraPlus Overview
- Year Founded
-
2018
- Status
-
Private
- Latest Deal Type
-
Later Stage VC
- Investors
-
4
NeuraPlus General Information
Description
Developer of non-invasive neuromodulation and bioelectronic medicine and devices intended for neurorehabilitation and cognitive disorder intervention in clinical research. The company is actively developing non-invasive neuromodulation system, brain-computer interface, smart wearable, mobile medical devices, and the company has developed a portable transcranial electrical stimulation training device, enabling patients with brain disease to obtain an effective treatment solutions.
Contact Information
Website
www.neuroplus.cnCorporate Office
- Room 302, Building C1, China Merchants Guangming Technology Park, Fenghuang Street
- Guangming District
- Shenzhen, Guangdong 518055
- China
Corporate Office
- Room 302, Building C1, China Merchants Guangming Technology Park, Fenghuang Street
- Guangming District
- Shenzhen, Guangdong 518055
- China
NeuraPlus Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC | 25-Nov-2024 | Completed | Generating Revenue | |||
| 3. Later Stage VC | 21-Jun-2024 | Completed | Generating Revenue | |||
| 2. Later Stage VC | 11-Aug-2023 | Completed | Generating Revenue | |||
| 1. Early Stage VC | 22-Sep-2022 | Completed | Generating Revenue |
NeuraPlus Patents
NeuraPlus Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025260523-A1 | Electrode positioning system based on personalized brain segmentation | Pending | 20-Jun-2024 | ||
| WO-2025162104-A1 | Electroencephalogram signal-based awakening method and apparatus for coma patient, electronic device, and storage medium | Pending | 31-Jan-2024 |
NeuraPlus Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Shanghai Daohe Long Term Investment Management | Growth/Expansion | Minority | ||
| Seven Seas Partners (China) | Venture Capital | Minority | ||
| Shenzhen Zhongke Scientific Technological Equity Investment Fund Management | Growth/Expansion | Minority | ||
| TigerYeah Capital | Venture Capital | Minority |
NeuraPlus FAQs
-
When was NeuraPlus founded?
NeuraPlus was founded in 2018.
-
Where is NeuraPlus headquartered?
NeuraPlus is headquartered in Shenzhen, China.
-
What industry is NeuraPlus in?
NeuraPlus’s primary industry is Therapeutic Devices.
-
Is NeuraPlus a private or public company?
NeuraPlus is a Private company.
-
What is NeuraPlus’s current revenue?
The current revenue for NeuraPlus is .
-
Who are NeuraPlus’s investors?
Shanghai Daohe Long Term Investment Management, Seven Seas Partners (China), Shenzhen Zhongke Scientific Technological Equity Investment Fund Management, and TigerYeah Capital have invested in NeuraPlus.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process